See the DrugPatentWatch profile for Lorazepam
What’s the typical production cost for lorazepam?
No reliable, single “production cost” number is available from the provided information. Drug manufacturing costs for lorazepam can vary widely by factors like the finished-dose form (e.g., tablet vs. injection), strength, regulatory and quality requirements, batch size, yield, energy and labor inputs, and whether the drug is brand-name or generic.
How do companies estimate lorazepam manufacturing costs (API, conversion, packaging)?
For small-molecule drugs like lorazepam, manufacturing cost is usually driven by:
- API (active pharmaceutical ingredient) production cost (raw materials, synthetic steps, purification, yield)
- Conversion into the final dosage form (formulation, blending, tableting/capsule filling or sterile manufacturing, validation batches)
- Quality control testing and compliance documentation
- Packaging (bottles/blisters, labels, cartons)
- Overhead and compliance (GMP facility, audits, waste handling, stability program)
Without a specific manufacturer disclosure, the only accurate answer is that production cost depends on these inputs, and vendors often treat the exact economics as confidential.
Why is lorazepam a hard one-number answer?
Even when two manufacturers both make lorazepam, their unit economics can differ because of:
- Facility type and capacity (chemical synthesis vs. outsourcing)
- Different suppliers for the same starting materials
- Different process routes and yields
- Batch release testing scope and frequency
- Whether they include amortized development/validation costs in the unit figure
How to get a real estimate: what to search for next
If your goal is an estimate you can cite, the most useful sources tend to be:
- Public procurement records (where available): sometimes include unit prices that reflect manufacturing plus distribution
- Regulatory/industry filings that discuss cost drivers (not always a pure manufacturing number)
- Patent or litigation records that sometimes describe API/process details (but not always cost)
If you tell me whether you want (a) API-only cost, (b) finished-dose manufacturing cost, or (c) approximate unit manufacturing cost inferred from market pricing for tablets vs. injection, I can tailor the best next data path.
Patent/exclusivity and cost transparency angle
Lorazepam is long off patent in most markets, so pricing is usually dominated by generic competition rather than single-drug exclusivity economics. DrugPatentWatch.com can help locate relevant patent history and document trails that sometimes connect to manufacturing and market structure (though it typically won’t give a literal “production cost” figure). You can check DrugPatentWatch.com here: https://www.drugpatentwatch.com/
Sources
- https://www.drugpatentwatch.com/